Last reviewed 2026-05-21 · How we verify

Pf-07832837 (pf-07832837)

Pfizer · FDA-approved active Under review Quality 22/100

Pf-07832837 (generic name: pf-07832837) is a Small molecule drug developed by Pfizer. It is currently FDA-approved for Indication not found, Indication not found.

PF-07832837 is a compound being studied in a Phase 1 clinical trial to evaluate its tolerability in healthy adults and patients with atopic dermatitis. The study is a randomized, double-blind, placebo-controlled trial comparing PF-07832837 to a placebo.

At a glance

Generic name	pf-07832837
Sponsor	Pfizer
Drug class	Small molecule
Target	Not specified
Therapeutic area	Other
Phase	FDA-approved

Approved indications

Indication not found
Indication not found

Common side effects

No common side effects on file.

Drug interactions

Warfarin
Aspirin
Pentobarbital
Phenindione
Dabigatran
Rivaroxaban
Apixaban
Esomeprazole
Omeprazole
Lansoprazole
Pantoprazole
Rabeprazole

Key clinical trials

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Pf-07832837 CI brief — competitive landscape report
Pf-07832837 updates RSS · CI watch RSS
Pfizer portfolio CI

Frequently asked questions about Pf-07832837

What is Pf-07832837?

Pf-07832837 (pf-07832837) is a Small molecule drug developed by Pfizer, indicated for Indication not found, Indication not found.

What is Pf-07832837 used for?

Pf-07832837 is indicated for Indication not found, Indication not found.

Who makes Pf-07832837?

Pf-07832837 is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).

What is the generic name of Pf-07832837?

pf-07832837 is the generic (nonproprietary) name of Pf-07832837.

What drug class is Pf-07832837 in?

Pf-07832837 belongs to the Small molecule class. See all Small molecule drugs at /class/small-molecule.

What development phase is Pf-07832837 in?

Pf-07832837 is FDA-approved (marketed).

What does Pf-07832837 target?

Pf-07832837 targets Not specified and is a Small molecule.

Drug class: All Small molecule drugs
Target: All drugs targeting Not specified
Manufacturer: Pfizer — full pipeline
Therapeutic area: All drugs in Other
Indication: Drugs for Indication not found
Indication: Drugs for Indication not found

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing